The Science Behind NMN and NAD⁺

Understanding NMN, NAD⁺, and Ongoing Human Research

NMN (nicotinamide mononucleotide) has gained scientific attention due to its role as a precursor to NAD⁺ (nicotinamide adenine dinucleotide), a molecule essential for cellular energy metabolism. Research into NMN focuses on how maintaining NAD⁺ levels may support normal cellular function during the aging process.

The Science Behind NMN and NAD⁺ NAD⁺ (nicotinamide adenine dinucleotide), a molecule essential for cellular energy metabolism.

Finding ways to boost your NAD⁺ levels has become the key to a longer life.

NAD⁺ Levels and Aging

Research shows that NAD⁺ levels naturally decline with age. This decline is associated with reduced cellular efficiency and changes in metabolic function observed over time.

Because NAD⁺ is a large molecule that does not efficiently cross cell membranes, researchers have explored precursor compounds – such as NMN, that the body can convert into NAD⁺ internally.

This conversion process allows NMN to support NAD⁺ availability at the cellular level. As a result, NMN has become a focus of scientific research related to energy metabolism and cellular maintenance.

What Is NAD⁺?

NAD⁺ is a naturally occurring molecule found in all living cells. It plays a critical role in multiple biological processes.

It is essential to maintain optimum cellular NAD+ to ensure we age healthily.

What Is NMN?

NMN (nicotinamide mononucleotide) is a naturally occurring compound and a direct precursor to NAD⁺. Once absorbed, NMN can be converted into NAD⁺ through established metabolic pathways.

This has made NMN a focus of scientific research examining whether increasing NAD⁺ availability may support normal cellular processes during aging.

How NMN Supports NAD⁺ Metabolism

Supplementing with NMN provides the body with a building block used in NAD⁺ synthesis. Studies indicate that NMN supplementation can increase blood NAD⁺ levels, allowing researchers to observe downstream effects related to cellular energy and metabolic activity.

It is important to note that NMN does not act as a drug; rather, it supports existing biological pathways involved in NAD⁺ metabolism.

Human clinical trials have demonstrated the benefits of supplementing with NMN

Human clinical studies have examined NMN supplementation across various populations to better understand its safety profile and physiological effects. These studies focus on markers such as NAD⁺ concentration, physical performance, metabolic indicators, and cellular function.

Safety & Efficacy

STUDY 1

Physical Performance

STUDY 2

Insulin Sensitivity

STUDY 3

Cardiovascular Health

STUDY 4

DNA Repair

STUDY 5

STUDY #1: Physical Performance and NAD⁺ Levels

CLINICAL RESEARCH FINDINGS

The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

CONCLUSIONS

  • Blood NAD concentrations were statistically significantly increased among all NMN-treated groups at day 30 and day 60 when compared to placebo group.
  • Blood NAD concentrations were highest in the groups taking 600 mg and 900 mg NMN. No safety issues, based on monitoring adverse events were found. NMN supplementation was well tolerated.
  • Walking distance increase during the six-minute walking test was statistically significantly higher in the 300 mg, 600 mg, and 900 mg groups compared to placebo at both days 30 and 60 with longest walking distances measured in the 600 mg and 900 mg groups.
  • NMN supplementation increases blood NAD concentrations and is safe and well tolerated with oral dosing up to 900 mg NMN daily. Clinical efficacy expressed by blood NAD concentration and physical performance reaches highest at a dose of 600 mg daily oral intake.

ABSTRACT

A clinical trial of 80 healthy middle-aged adults given oral doses of NMN at 300 mg, 600 mg, or 900 mg over 60 days to evaluate blood NAD concentration with dose dependent regimens.

DATE: Feb 2023

STUDY #2: Metabolic Markers in Older Adults

CLINICAL RESEARCH FINDINGS

Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.

CONCLUSIONS

  • NMN administration safely increased circulating NAD levels in the test subjects.
  • Significant reduction seen in total LDL and non-HDL cholesterol, body weight and diastolic blood pressure.
  • These data provide the rationale for larger trials to further assess the efficacy of NAD augmentation in improving cardiometabolic outcomes in older adults.

ABSTRACT

A clinical trial of 30 overweight or obese adults > 45 years given oral doses of NMN at 1000 mg or a placebo daily for 28 days to evaluate body weight, liver, muscle, intra-abdominal at, insulin sensitivity, blood pressure, lipids, physical performance, and muscle bioenergetics.

DATE: July 2023

STUDY #3: Insulin Sensitivity in Women

CLINICAL RESEARCH FINDINGS

Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

CONCLUSIONS

  • Insulin stimulated glucose disposal increased after NMN supplementation compared to the placebo group.
  • NMN supplementation up-regulated the expression of platelet-derived growth factor receptor β and other genes related to muscle re-modeling.
  • These results demonstrate that NMN increases muscle insulin sensitivity, insulin signalling, and re-modeling in women with prediabetes who are overweight or obese.

ABSTRACT

A 10 week clinical trial of postmenopausal women with prediabetes who were overweight or obese given oral doses of NMN at 250 mg or a placebo daily to evaluate the effect of NMN supplementation on metabolic function.

DATE: June 2021

STUDY #4: Aerobic Capacity and Exercise

CLINICAL RESEARCH FINDINGS

Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study.

CONCLUSIONS

  • Oxygen uptake (VO2) and Ventilatory threshold (VT) increased to a greater degree in the group supplementing NMN at 600 mg/day and 1200 mg/day.
  • NMN increases the aerobic capacity of humans during exercise training, and the improvement is likely the result of enhanced O2 utilization of the skeletal muscle which appears to be one of the most sensitive tissues to NMN in humans.

ABSTRACT

A 6 week clinical trial of 48 young and middle-aged recreationally trained runners aged 27-50 years were given oral doses of either a placebo, NMN at 300 mg, 600 mg, or 1200mg daily to evaluate the effect of NMN supplementation on aerobic capacity of runners.

DATE: July 2021

STUDY #5: Cellular Aging Markers

CLINICAL RESEARCH FINDINGS

The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase.

CONCLUSIONS

  • The telomere length (TL) of clinical subjects was observed to have increased significantly after 30 days of NMN supplementation.
  • Telomere length has been documented as an important feature of aging and observed to shorten over time. The documented increase in TL from NMN supplementation suggests the potential of NMN use at a pre-aging phase to retard the proceeding of aging.

ABSTRACT

A 90 day clinical trial of 8 healthy men aged 45-60 years (pre-aging phase) given NMN at 300mg/day dosage to evaluate the supplementary effect on the telomere length of the peripheral blood mononuclear cell (PBMC).

DATE: November 2021

NMN Safety and Ongoing Research

NMN has been examined in multiple human studies and is generally reported as well tolerated within studied dosage ranges; however, NMN research is ongoing and long-term effects continue to be evaluated. Individuals considering NMN supplementation should focus on product quality, manufacturing standards, and independent testing, and consult healthcare professionals if they have medical concerns.

NMN vs NR (Nicotinamide Riboside)

Both NMN and NR are NAD⁺ precursors studied for their role in NAD⁺ metabolism. Research continues to explore differences in absorption, conversion pathways, and physiological outcomes. Current studies suggest both compounds contribute to NAD⁺ production through distinct biological mechanisms.

Scientific Context and Responsible Use

NMN research represents an evolving field within cellular and aging science. While human studies provide valuable insights, results vary based on study design, dosage, and population.This information is provided for educational purposes and should not be interpreted as medical advice.

For those interested in NMN supplementation, choosing products manufactured under verified quality standards and independent testing is an important consideration.

Explore NMN Options!

FAQs about NMN Science

NMN (Nicotinamide Mononucleotide) is a naturally occurring compound and a direct precursor to NAD⁺ (Nicotinamide Adenine Dinucleotide). After ingestion, NMN is converted into NAD⁺, a molecule essential for cellular energy production, DNA repair, and metabolic function.

NAD⁺ is a coenzyme involved in mitochondrial energy production and cellular repair processes. NAD⁺ levels naturally decline with age, which is associated with reduced cellular efficiency and metabolic function. Supporting NAD⁺ levels is an area of active scientific research in ageing and longevity.

Human clinical studies have shown NMN supplementation to be well tolerated when taken within studied dosage ranges. Safety outcomes in published trials report no significant adverse effects. Individuals with medical conditions should consult a healthcare professional before use.

NAD⁺ itself is a large molecule and is not efficiently absorbed by cells when taken directly. NMN, as a smaller precursor molecule, can be absorbed and then converted into NAD⁺ inside the body, which is why NMN is commonly used in NAD⁺ research.

Multiple human clinical trials have demonstrated that NMN supplementation can increase blood NAD⁺ levels and support functions related to physical performance, metabolic health, and cellular processes. Research on NMN is ongoing, with growing interest globally.